Jpmorgan Chase & CO Femasys Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.31 - $2.98 $959 - $9,220
-3,094 Reduced 99.65%
11 $0
Q2 2023

Aug 11, 2023
BUY
$0.51 - $1.26 $1,583 - $3,912
3,105 New
3,105 $1,000
Q2 2022

Aug 11, 2022
SELL
$1.3 - $2.76 $114 - $242
-88 Reduced 73.33%
32 $0
Q1 2022

May 11, 2022
BUY
$1.76 - $3.99 $211 - $478
120 New
120 $0

Others Institutions Holding FEMY

# of Institutions
26
Shares Held
1.57M
Call Options Held
0
Put Options Held
0
View Full List

About FEMASYS INC

FEMY Quotes by TradingView
  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $13.5M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email